Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Call for responsible prescribing decisions under cascade
Companion animal vets observed the conflict most with prescriptions for dogs, rabbits and cats.
Survey reveals concern some decisions could exacerbate AMR

Ahead of World Antibiotic Awareness Day (18 November), the BVA and the VMD are highlighting to vets the importance of making responsible prescribing decisions under the cascade.

The advice comes after BVA’s Voice of the Veterinary Profession’s survey revealed that 60 per cent of vets felt that unquestioningly using the cascade could result in decisions that did not meet the criteria for responsible prescribing.

The survey also found the perceived conflict is apparent across all major practice specialisms. Large animals vets were much less likely to identify it, however, with only 41 per cent observing the issue and 24 per cent seeing it often or sometimes.  

Companion animal vets observed the conflict most with prescriptions for dogs, rabbits and cats, while large animal and mixed practice vets observed it most with cattle and sheep. Mixed practice vets said they also experienced it with prescribing decisions for exotics too.

“The cascade provides much-needed flexibility in allowing veterinary surgeons to treat animals in situations where a licensed product for a condition in a particular species is not available in the UK, but we are concerned that it could in some circumstances lead to decisions that could exacerbate antimicrobial resistance,” said BVA president Simon Doherty.
 
“While there is a legislative requirement to use a UK-authorised veterinary medicine before applying the cascade, there is concern among our members that there are instances where following the procedure could lead to inappropriate prescribing decisions. This is especially true when vets are trying to balance the use of the cascade with the responsible use of critically important antibiotics.
 
He continued: “With antibiotic resistance a very real and urgent concern, our message to vets is to continue to use their professional judgement, on a case-by-case basis, in considering alternative prescribing options, after giving full consideration to potential risks. A commitment from each of us within the veterinary profession to maintain the highest standards of stewardship in using antimicrobials, most especially CIAs, is the only way we can preserve these essential medicines for future generations.”

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.